GI Pathology: Esophagitis to Colorectal Tumors

GI pathology covers diseases of the digestive tract from esophagus to rectum. The big themes repeat along the tube: inflammation (esophagitis, gastritis, inflammatory bowel disease), ulcers (peptic ulcer disease), and tumors — benign polyps that can turn malignant, and colorectal cancer, among the world's most common cancers.

This matters because digestive symptoms — heartburn, pain, bleeding, changed bowel habits — are top reasons for doctor visits, and the benign-versus-malignant distinction is decided by endoscopy and biopsy. Knowing which lesions are precancerous underpins screening programs that save millions of lives.

Key Concepts

• Esophagitis: reflux esophagitis (GERD acid) is most common; eosinophilic and infective forms (Candida, herpes, CMV) occur in immunocompromised patients. Chronic reflux causes Barrett's esophagus, intestinal metaplasia that can progress to adenocarcinoma.
• Gastritis and peptic ulcer: Helicobacter pylori and NSAIDs dominate. H. pylori causes most duodenal ulcers; NSAIDs block protective prostaglandins causing gastric ulcers. Duodenal ulcer pain eases with food and wakes patients at night; gastric ulcer pain worsens with food.
• Inflammatory bowel disease: Crohn's disease (any GI segment, transmural, skip lesions, cobblestone mucosa) versus ulcerative colitis (colon only, continuous from rectum, mucosal). Both raise colorectal cancer risk.
• Colorectal polyps and cancer: adenomatous polyps are precancerous — the adenoma–carcinoma sequence takes ~10–15 years, which is why 10-yearly colonoscopy works. Hyperplastic polyps are harmless. Cancers spread to nodes, then liver via portal blood.
• Celiac disease: gluten-triggered villous damage causing malabsorption; diagnosed by anti-tTG antibodies and biopsy.

How It Works

1. Defense fails: acid, H. pylori, NSAIDs or immune attack breaches the mucosal barrier.
2. Inflammation: gastritis in the stomach, crypt abscesses in ulcerative colitis, transmural granulomas in Crohn's.
3. Ulceration or chronicity: acute breaches become peptic ulcers; persistent immune activation becomes IBD with flares and remissions.
4. Dysplasia: chronic injury (Barrett's, long-standing colitis, adenomas) produces precancerous cells.
5. Carcinoma: mutations convert dysplasia to invasive cancer. Removing polyps or dysplastic segments interrupts the sequence — the whole logic of screening.

Worked Example

A 45-year-old man has burning upper-abdominal pain waking him at 2 a.m., eased by eating. Step 1: pain relieved by food plus nocturnal pain is classic duodenal ulcer (gastric ulcer pain worsens with food). Step 2: test for H. pylori (stool antigen or urea breath test) and ask about NSAIDs — the two causes behind most ulcers. Step 3: breath test positive. Step 4: triple therapy — a proton-pump inhibitor plus two antibiotics for 14 days — eradicates H. pylori in most cases. Step 5: confirm cure with a repeat breath test 4 weeks later and advise NSAID avoidance.

Common Misconceptions

• "Ulcers come from stress and spicy food." These aggravate symptoms, but H. pylori and NSAIDs are the actual causes — treating stress alone lets ulcers recur.
• "All colon polyps become cancer." Only adenomatous polyps are precancerous, needing 10–15 years. Hyperplastic polyps are harmless — the pathology report decides risk.
• "Crohn's and ulcerative colitis are the same." They differ in location, depth, pattern and complications — and some treatments work for one but not the other.

Real-World Applications

• Screening: colonoscopy from age 45 removes adenomas in the 10–15-year window before cancer; FIT stool tests triage who needs scoping.
• H. pylori test-and-treat: cures most ulcers and reduces gastric cancer risk in high-prevalence populations.
• IBD management: the Crohn's-vs-colitis distinction guides drug choice and surgery — colectomy cures ulcerative colitis but not Crohn's.
• Surveillance: Barrett's esophagus and long-standing colitis enter scheduled endoscopy to catch dysplasia while curable.

From esophagitis to colorectal tumors, GI pathology follows one arc: barrier failure, inflammation, ulceration, dysplasia, cancer — and every step is an intervention opportunity. Learn the pain patterns, the two ulcer causes, the Crohn's–colitis split and the adenoma–carcinoma timeline.